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INTESTINAL ISCHEMIA/REPERFUSION INDUCES
BRONCHIAL HYPERREACTIVITY AND INCREASES
SERUM TNF-α IN RATS
Marcio Jose Cristiano de Arruda, Renato Sergio Poggetti, Belchor Fontes, Riad
N.Younes, Almerindo Lourenço Souza Jr., and Dario Birolini
Arruda MJC de, Poggetti RS, Fontes B, Younes RN, Souza Jr. AL, Birolini D. Intestinal ischemia/reperfusion induces
bronchial hyperreactivity and increases serum TNF-α in rats. Clinics. 2006;61(1):21-8.
INTRODUCTION: Intestinal or hepatic ischemia/reperfusion induces acute lung injury in animal models of multiple organ
failure. Tumor necrosis factor (TNF)- α is involved in the underlying inflammatory mechanism of acute respiratory distress
syndrome. Although the inflammatory cascade leading to acute respiratory distress syndrome has been extensively investigated,
the mechanical components of acute respiratory distress syndrome are not fully understood. Our hypothesis is that splanchnic
ischemia/reperfusion increases airway reactivity and serum TNF-α levels.
OBJECTIVE: To assess bronchial smooth muscle reactivity under methacholine stimulation, and to measure serum TNF-α
levels following intestinal and/or hepatic ischemia/reperfusion in rats.
METHOD: Rats were subjected to 45 minutes of intestinal ischemia, or 20 minutes of hepatic ischemia, or to both (double
ischemia), or sham procedures (control), followed by 120 minutes of reperfusion. The animals were then sacrificed, and the
bronchial response to increasing methacholine molar concentrations (10-7 to 3 x 10-4) was evaluated in an ex-vivo bronchial
muscle preparation. Serum TNF-α was determined by the L929-cell bioassay.
RESULTS: Bronchial response (g/100 mg tissue) showed increased reactivity to increasing methacholine concentrations in the
intestinal ischemia and double ischemia groups, but not in the hepatic ischemia group. Similarly, serum TNF-α (pg/mL) concentration
was increased in the intestinal ischemia and double ischemia groups, but not in the hepatic ischemia group.
CONCLUSION: Intestinal ischemia, either isolated or associated with hepatic ischemia, increased bronchial smooth muscle
reactivity, suggesting a possible role for bronchial constriction in respiratory dysfunction following splanchnic ischemia/reperfusion.
This increase occurred in concomitance with serum TNF-α increase, but whether the increase in TNF-α caused this bronchial
contractility remains to be determined.
KEYWORDS: Mechanical factor of ARDS. Bronchial contractility. Intestinal and hepatic ischemia.
INTRODUCTION
Despite recent improvements in trauma care, acute res-
piratory distress syndrome (ARDS) remains a common
complication in trauma patients sustaining severe
hemorrhagic shock. ARDS contributes to the multiple or-
gan dysfunction syndrome (MODS), which is the leading
cause of death in these patients.1 Although continually un-
der investigation, the mechanisms of ARDS and MODS are
still not fully understood. Most studies focus on the inflam-
matory component of these syndromes.2,3 However, some
clinical observations have shown that ARDS patients have
mechanical respiratory disturbances, basically decreased
pulmonary compliance and increased airway resistance,4-6
suggesting that a mechanical component may have a role
in the underlying mechanism of this syndrome.
Hemorrhagic shock, frequently associated with impaired
mesenteric blood flow and tissue ischemia, is a common
22
CLINICS 2006;61(1):21-8Intestinal ischemia/reperfusion induces bronchial hyperreactivity
Arruda MJC et al.
event in trauma patients.7 The successful management of
shock with aggressive fluid replacement restores tissue
reperfusion, but may be followed by the systemic inflam-
matory response syndrome (SIRS) and reperfusion injury
to the lung (acute lung injury – ALI) and other organs, lead-
ing to ARDS and MODS.8–11 It has been shown that after
45 minutes of intestinal ischemia (II) followed by 2 hrs of
reperfusion, acute lung injury (ALI) is observed, with in-
creased lung vascular permeability and lung neutrophil se-
questration.12–17
Using this model, it has more recently been shown in
our laboratory that, after 60 minutes of reperfusion, lung
macrophages are activated, with significant TNF-α and
H2O2 production.18 Besides its well-known action as inflam-
matory mediator, TNF-α has been suggested as a possible
mediator of airway hyperreactivity, although the mecha-
nism for this action is still not clear.19–21
The surgical control of bleeding liver injuries in trauma
patients with hemorrhagic shock usually requires special
maneuvers,22–23 such as temporary clamping of the hepatic
pedicle (Pringle’s maneuver),24 resulting in HI followed by
reperfusion (hepatic I/R). Hepatic I/R leads to the release
of inflammatory mediators and may result in the develop-
ment of ARDS and MODS.16,25 Thus, liver I/R and intesti-
nal I/R are commonly associated events in patients sustain-
ing liver injury and hemorrhagic shock. However, the as-
sociated effect of intestinal I/R and liver I/R on the devel-
opment of ARDS and MODS has not been clearly estab-
lished.
Based on clinical observation, the 20-minute period of
HI resulting from Pringle’s maneuver was traditionally ac-
cepted as a safe procedure for the patient, although with-
out solid support from histology or laboratory investiga-
tion.27 More recently, total hepatic pedicle clamping for 30
minutes has been employed in trauma patients sustaining
severe liver injuries.28 It has also been shown in rat mod-
els that HI followed by reperfusion is associated with in-
creased serum levels of TNF.29 However, given the diver-
sity of TNF actions in the mechanism of inflammatory re-
sponse, the real role of TNF in the mechanism of lung and
liver injury following II or HI has not been clearly deter-
mined. Furthermore, the effect of intestinal I/R and liver
I/|R on the possible mechanical component of ARDS has
not been reported.
Our hypothesis was that splanchnic ischemia/
reperfusion induces increased airway reactivity and in-
creased serum levels of TNF-α. Therefore, the objective
of this study was to assess bronchial smooth muscle reac-
tivity as well as serum TNF-α levels after intestinal and/
or HI followed by reperfusion in rats.
MATERIALS AND METHODS
Wistar male rats (290-390 g) from the animal facility
of the University of São Paulo School of Medicine were
employed throughout the experiments. All animals received
humane care in compliance with the NIH Guide For Care
And Use Of Laboratory Animals, publication 85-23, revised
1985. The study protocol was approved by the Institutional
Ethics Committee for animal use in research studies. All
surgical procedures were performed under general
anesthesia with chloral hydrate (400 mg/kg, i.p.).
Anesthetized animals were randomized into 4 groups as
follows: 1) Control group (n = 11): sham procedure; 2) In-
testinal ischemia (II) group (n = 7): 45 minutes superior
mesenteric artery occlusion; 3) Hepatic ischemia (HI) group
(n = 8): 20 minutes of hepatic pedicle clamping; 4) Dou-
ble ischemia (DI) group: concomitant II and HI (n = 8).
In the control group, a median laparotomy was per-
formed, the superior mesenteric artery (SMA) and the he-
patic pedicle were gently exposed, and the animals were
observed for a time period equivalent to that of ischemia
in the corresponding experimental (II, DI, HI) groups. Dur-
ing this period the laparotomy incision was covered with
a plastic wrap to prevent fluid loss. The laparotomy inci-
sion was then closed with monofilament running suture, and
the animals were observed during the following 120 min-
utes corresponding to the reperfusion period of the other 3
groups. For intestinal I/R, the same procedures as in the
control group were performed, except that at the end of vas-
cular exposure, the superior mesentery artery was occluded
with a vascular clamp (Vascu-statt no. 1001-531, Scalan
International, Minn. 55107, USA) for 45 minutes. For liver
ischemia, the hepatic pedicle was occluded with a clamp
for 20 minutes; in the DI group, this clamp was applied at
25 minutes of the II period, and removed at the end of the
45 minutes of II. At the end of the ischemia, the clamp on
the SMA and on the hepatic pedicle were removed, and
the laparotomy incision was closed as in the control group.
The time period of reperfusion was 120 minutes in all
groups. A pilot study (data not shown) indicated that 45
minutes of II combined with 30 minutes of HI (initiated
after 15 minutes of II) resulted in a mortality rate of 30%
within 72 hours following the end ischemia; therefore, the
period of HI was reduced to 20 minutes (beginning after
25 minutes of II), and no death occurred.
Set-up of the isolated intrapulmonary bronchial segment.
At the end of reperfusion, a median thoracotomy was
performed, and the left intrapulmonary bronchial segment
was removed and dissected free of connective tissue. The
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bronchial segment was suspended on 2 steel hooks in an
8-mL organ bath containing Krebs-Henseleit buffer solu-
tion aerated with 95% O2 and 5% CO2 and maintained at
36.5oC. Isometric contractions were evaluated using a
Narco F60 force displacement transducer connected to a
Physiograph MKIII recorder. The intrapulmonary bronchial
segment was allowed to equilibrate for 60 minutes under
an initial tension of 500 mg. During this period, the bath-
ing medium was replaced every 20 minutes. After equili-
bration, the tension was adjusted to the optimal length-ac-
tive tension (1 g). The tissue viability of the bronchial seg-
ment was assessed by the contraction-eliciting procedure,
in which the contraction of the viable bronchial segment
is elicited by replacing the Krebs buffer solution with iso-
osmolar Krebs-bicarbonate solution containing 60 mM
KCl.30,31
Dose response curve to methacholine
Once the tissue viability was determined, the organ bath
fluid was refilled with Krebs solution, and the dose re-
sponse curve was determined to methacholine, a muscarinic
agonist commonly used in experimental models of bron-
chial contractility.31 For this purpose, isolated increasing
doses of methacholine (10-7 to 10-3 molar) were added to
the organ bath, and the force developed by the bronchial
segment was recorded. The contractile effect of each dose
of methacholine was observed until the maximum effect
was reached (20 seconds to 2 minutes after the drug addi-
tion).
Quantitation of serum TNF-α activity.
At the end of reperfusion, blood samples were drawn
from the heart by needle punction. The samples were kept
on ice for 30 minutes for clot retraction, centrifuged at
1,620 g for 15 minutes, and the serum harvested for TNF-
α activity quantitation. TNF-α activity was measured by
cytotoxicity assay using L-929 tumor cells.32 Briefly, 50 mL
of serum was pipetted into 96-well microtiter plates con-
taining target L-929 cells (5 x 104 cells/50 mL) in the pres-
ence of actinomycin D (final concentration 5 mg/mL). The
cells were incubated with rat serum samples for 24 h at
37oC. The supernatant was then discarded, and adherent
cells were washed with PBS and stained with crystal vio-
let for 15 minutes. The absorbance of the samples was read
at 620 nm (ELISA Titertek Multiskam). TNF-α concen-
tration (units/mL) was defined as the reciprocal of the di-
lution that induced 50% lysis of L-929 cells. In standard
curves, 50% cytotoxicity was obtained with a dose of 9.2
pg recombinant rat TNF-α.
Statistics
Data are presented as mean ± SEM. The studied vari-
ables were compared using the fixed factor analysis of vari-
ance (ANOVA) F test. When a significant result was ob-
tained using this test, the differences were identified by
means of the multiple comparisons Scheffe test. Data nor-
mality was analyzed using the Shapiro-Silks test.
Nonparametric tests were employed for the analysis of data
presenting great variability, where the supposition of nor-
mality was not fulfilled. For comparison of groups as to
these variables, the Kruskal-Wallis (H) test for independ-
ent variables was employed. Differences with a P < .05
were considered statistically significant and denoted with
an asterisk (*).
RESULTS
Bronchial contractility
Comparison of bronchial response to different levels of
methacholine stimuli in the 4 groups (II, HI, DI, and con-
trol) is shown in Figure 1. For concentrations of 10-7 to 3 x
10-7 molar methacholine, there was no difference between
experimental and control groups. For methacholine concen-
trations from 10-5 to 3 x 10-4 molar, intestinal ischemia pro-
voked significantly increased bronchial contractility when
compared to results of the control group. Bronchial
contractility of the HI group was not different from that of
the control group. However, in the DI group, the bronchial
contractility was significantly different from that of the con-
trol group at methacholine concentrations starting at 3 x
10-7 molar.
Serum TNF-α
Serum TNF-α levels in the II (631 ± 185 pg/mL) and
DI (539 ± 121 pg/mL) groups were significantly higher
compared to TNF-α levels in the HI (118 ± 43 pg/mL) and
control (54 ± 31 pg/mL) groups (Figure 2).
DISCUSSION
Clinical observations in ARDS patients have shown in-
creased airway resistance to air flow and have suggested a
therapeutic effect for the use of beta-agonist
(metaproterenol) and salbutamol inhalation.33,34 Experimen-
tal and clinical investigations on the mechanism of ARDS
have been mostly focused on the role of cellular and hu-
moral mediators of the underlying inflammatory response,
and they have further suggested a possible role for humoral
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inflammatory mediators, more specifically TNF-α, in the
increased bronchial reactivity.19,35–38 It has been shown, for
instance, that animals treated with TNF-α inhalation pre-
sented increased airway resistance, and that pretreatment
with a TNF-α receptor antagonist reversed this response.19, 38
However, the actual role of increased bronchial reactivity
in the mechanism of ARDS remains to be elucidated. The
experimental models of intestinal ischemia (II) or hepatic
ischemia (HI) have been largely employed to investigate
the mechanism of acute lung injury, mimicking what hap-
pens in ARDS trauma patients.14,25,26
In the present study, using a rat model of ischemia/
reperfusion (I/R), we investigated the mechanical compo-
nent of I/R on acute lung injury (ALI) in response to II
and HI provoked either simultaneously or separately. This
investigation was carried out by assessing serum TNF-α
levels, as well as the response of airway smooth muscle to
cholinergic stimuli, using a dose-response curve with 8 dif-
ferent molar concentrations (10-7 to 3 x 10-4 molar) of
methacholine. In an attempt to use a nonlethal stimulus that
provokes acute lung injury, we adopted 45 minutes of II
and 20 minutes of HI, followed by 120 minutes of
reperfusion to both organ territories. Metabolic or
hemodynamic evaluation was not included in this study,
since it would have required animal manipulation for blood
vessel catheterization and blood sampling, with potential
adverse influences on the results.
The reason for the choice of the experimental model
of simultaneous 45 minutes of II and 20 minutes of HI in
the present study was that we were seeking a nonlethal rat
model of combined II and HI leading to lung and liver in-
jury. Thus, the model with 45 minutes of isolated II was
chosen because it has been frequently used, and it has been
shown to provoke lung and liver injury that is detectable
at 6 hours of reperfusion and is reversible at 18 hours, with
no mortality.3,15, 39–41
Concerning the HI provoked by hepatic pedicle clamp-
ing, different ischemia periods have been previously re-
ported, with mortality rates not clearly established. For in-
stance, while some investigators have reported no mortal-
ity for an HI period of 30 minutes,42 or for periods shorter
than 45 minutes,43 a 9% mortality after 30 minutes of HI
was reported by others.44 Additionally, a reversible increase
in serum TNF-α levels was observed after 30 minutes of
hepatic pedicle occlusion followed by 120 minutes
reperfusion, with no mortality in rats.42 In a pilot study of
45 minutes of II combined with 30 minutes of HI, we ob-
Legend:  Animal preparation: anesthesia + laparotomy + superior mesenteric artery (SMA) and hepatic pedicle (HP) identification
Figure 1 - Diagram: Main steps of the experiment
II = intestinal ischemia; DI = double (intestinal and hepatic) ischemia; HI =
hepatic ischemia; Sham = control group; * = p< 0.05 compared with Sham.
Figure 2 - Serum concentrations of TNF-a after intestinal and/or hepatic
ischemia
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served a 30% mortality rate within 72 hours of reperfusion,
whereas no death occurred when the HI period was reduced
to 20 minutes. On the other hand, 20 minutes of total he-
patic pedicle occlusion provoked increased intercellular
spaces, decreased cytoplasm glycogen, and the presence of
membrane vesicles in the cytoplasm of rat hepatocytes, sug-
gesting that 20 minutes of HI is not an innocuous stimulus
(Poggetti RS, unpublished data). Therefore, we used the
combined model of 45 minutes II with 20 minutes HI in
the present study.
In this study, we found that the animals subjected to
intestinal ischemia presented a significant increase in bron-
chial reactivity to the 4 highest doses of methacholine used.
Also in the animals subjected to double (intestinal and he-
patic) ischemia, a significant increase in bronchial reactivity
was observed. However, in the animals subjected to iso-
lated HI, the bronchial response to methacholine was not
different from that observed in the control animals. Fur-
thermore, our results also show that the serum TNF-α con-
centration was significantly increased in the animals sub-
jected to II, as well as to double ischemia, but not in the
animals subjected to isolated HI, compared to control ani-
mals. Considering that a nonlethal stimulus (45 min of II
and 20 min of HI) was employed in this study and that HI
(either isolated and/or combined with II) did not add a sig-
nificant increase to the bronchial response to methacholine
or to TNF-α release, this finding indicates that 20 minutes
of HI may be an insufficient stimulus for either TNF-α pro-
duction or bronchial contractility.
It should also be considered that, in addition to lung
injury, the 45 minutes of II followed by 120 minutes
reperfusion also provokes liver injury.15 The potential im-
pact of this hepatic injury on the effects of HI was not con-
sidered in the present study. Other studies with longer pe-
riods of HI, either isolated or combined with II, might help
to clarify whether HI may stimulate bronchial contractility
and TNF-α release. In this context, it may be noted that
other similar situations have been studied, as for instance
the effects of allopurinol and streptokinase, which have
been shown to affect the outcome of lower limb ischemia/
reperfusion in rats45.
Studying the direct effect of TNF-α on pig tracheal
smooth muscle, Pennings et al found increased contractile
reactivity to cholinergic stimuli and showed that the use
of soluble TNF-α receptors abolished these effects.38 This
TNF-α action may be explained by the fact that TNF-α,
like other cytokines, is capable of altering the expression
of prejunctional M2 subtype muscarinic receptors; these
receptors are responsible for the negative feedback regula-
tion of acetylcholine release at the synaptic cleft. At the
intracellular level, TNF-α can stimulate the production of
transcription factors that impair the production of these
muscarinic receptors.46, 47 It has been also shown that TNF-
α increases G-protein affinity for M2-muscarinic receptors
on rabbit airway smooth muscles, leading to a decreased
smooth muscle relaxation in the presence of α-adrenergic
stimuli.37,48
In conclusion, our finding that intestinal I/R provokes
bronchial smooth muscle hyperreactivity in response to
methacholine seems support the hypothesis that the respi-
ratory dysfunction resulting from splanchnic ischemia has
a mechanical component involving bronchial constriction.
The findings of a simultaneous increase in serum TNF-α
levels and bronchial hyperreactivity after intestinal I/R war-
rant further study to clarify the possible role of TNF-α in
this phenomenon. Our results suggest also that HI of 20
minutes duration may be an insufficient stimulus to induce
bronchial constriction or TNF-α release. Further studies are
warranted to determine the possible role of hepatic
ischemia in bronchial hyperreactivity.
RESUMO
Arruda MJC de, Poggetti RS, Fontes B, Younes RN, Souza
Jr. AL, Birolini D. A isquemia/reperfusão intestinal provoca
hiper-reatividade brônquica e aumento do TNF-α sérico em
ratos. Clinics. 2006;61(1):21-8.
INTRODUCÃO: A isquemia/reperfusão intestinal ou
hepática induz lesão pulmonar aguda em modelos animais
de falência de múltiplos órgãos. O fator de necrose tumoral
(TNF-α) está envolvido no mecanismo inflamatório da
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síndrome da angústia respiratória aguda. Embora a cascata
inflamatória que leva à síndrome da angústia respiratória
aguda tenha sido extensamente investigada, os componentes
mecânicos desta ainda não são completamente compre-
endidos. Nós levantamos a hipótese de que a isquemia/
reperfusão esplâncnica provoca aumento da reatividade
contráctil das vias aéreas, bem como aumento do TNF-α
sérico.
OBJETIVO: avaliar a reatividade da musculatura lisa
brônquica sob estimulação com metacolina, e medir os
níveis séricos de TNF-α após isquemia/reperfusão intesti-
nal e/ou hepática em ratos.
MÉTODO: Ratos Wistar foram submetidos a 45 min de
isquemia intestinal, ou 20 minutos de isquemia hepática,
ou a ambas (isquemia dupla), ou controle, seguidos por 120
min de reperfusão. A resposta brônquica a concentrações
molares (10-7 to 3x10-4) de metacolina foi avaliada usando-
se uma preparação ex-vivo de musculatura brônquica.
RESULTADOS: A resposta brônquica (g/100mg de tecido)
mostrou reatividade aumentada a concentrações crescentes
de metacolina na isquemia intestinal e isquemia dupla, mas
não na isquemia hepática. Similarmente, o TNF-α sérico
aumentou na isquemia intestinal e isquemia dupla, mas não
na isquemia hepática.
CONCLUSÃO: Isquemia intestinal, quer isolada ou
associada à hepática, provocou hiper-reatividade da
musculatura brônquica, sugerindo um possível papel da
constrição brônquica na disfunção respiratória conseqüente
à isquemia/reperfusão esplâncnica. Este aumento foi
simultâneo ao do TNF-α sérico, porém o possível efeito
causal do TNF-α na contractilidade brônquica permanece
a ser determinado.
UNITERMOS: SARA. Contractilidade brônquica.
Isquemia intestinal e hepática.
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